Beauty Health CSO/COO granted 746K RSUs

Beauty Health Co reported that CSO and COO Sheri Lewis received an equity compensation grant of 746,681 restricted stock units (RSUs) of Class A Common Stock.

Rhea-AI Filing Summary

Beauty Health Co reported that CSO and COO Sheri Lewis received an equity compensation grant of 746,681 restricted stock units (RSUs) of Class A Common Stock. Each RSU represents a contingent right to receive one share, subject to time-based vesting and continued service conditions.

The RSUs vest in three equal installments on each of the first three anniversaries of the March 20, 2026 grant date, with certain acceleration rights. Following this grant, Lewis beneficially owns 1,609,524 shares of Class A Common Stock directly, reflecting a large, compensation-related, non-market acquisition rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 746,681 shares

Grant/Award 1 txn

Insider Lewis Sheri

Role CSO and COO

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	746,681	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 1,609,524 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Beauty Health Co (SKIN) report for Sheri Lewis?

Beauty Health Co reported that CSO and COO Sheri Lewis received 746,681 restricted stock units. These RSUs are equity compensation, not an open-market purchase, and increase her direct beneficial ownership to 1,609,524 shares of Class A Common Stock after the grant.

How many RSUs did Sheri Lewis receive from Beauty Health Co (SKIN)?

Sheri Lewis received a grant of 746,681 restricted stock units of Class A Common Stock. Each RSU represents a contingent right to one share, subject to time-based vesting conditions and continued service with Beauty Health Co through each applicable vesting date.

How do Sheri Lewis’s RSUs at Beauty Health Co (SKIN) vest over time?

The RSUs granted to Sheri Lewis vest in one-third increments on each of the first three anniversaries of the March 20, 2026 grant date. Vesting requires her continued service with Beauty Health Co and is also subject to certain acceleration rights described in the award terms.

What is Sheri Lewis’s share ownership after the RSU grant at Beauty Health Co (SKIN)?

After the RSU grant, Sheri Lewis is reported to beneficially own 1,609,524 shares of Class A Common Stock directly. This total includes the effect of the 746,681 RSUs awarded, which are equity compensation that settle into shares as vesting conditions are satisfied over time.

Is Sheri Lewis’s RSU award at Beauty Health Co (SKIN) an open-market share purchase?

No, the transaction is classified as a grant or award acquisition, not an open-market purchase. The 746,681 RSUs are equity compensation that convert into shares only if time-based vesting and continued service conditions are met, rather than being bought on the stock market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 05:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lewis Sheri

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH CALIFORNIA 90815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CSO and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		A(1)		746,681	A	(1)	1,609,524	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

Remarks:

	/s/ Paul Bokota, Attorney-in-fact for Sheri Lewis	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)